Zobrazeno 1 - 10
of 59
pro vyhledávání: '"DAI TAKAMATSU"'
Autor:
Shigehiro Tsukahara, Masaki Shiota, Dai Takamatsu, Shohei Nagakawa, Takashi Matsumoto, Ryo Kiyokoba, Mikako Yagi, Daiki Setoyama, Nozomi Noda, Shinya Matsumoto, Tetsutaro Hayashi, Alberto Contreras-Sanz, Peter C. Black, Junichi Inokuchi, Kenichi Kohashi, Yoshinao Oda, Takeshi Uchiumi, Masatoshi Eto, Dongchon Kang
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Chemotherapy is a standard therapy for muscle-invasive bladder cancer (MIBC). However, genomic alterations associated with chemotherapy sensitivity in MIBC have not been fully explored. This study aimed to investigate the genomic landscape o
Externí odkaz:
https://doaj.org/article/592f640d5f66404789c46f9398fa543d
Autor:
Yu Toda, Kenichi Kohashi, Hidetaka Yamamoto, Shin Ishihara, Yoshihiro Ito, Yosuke Susuki, Kengo Kawaguchi, Daisuke Kiyozawa, Dai Takamatsu, Izumi Kinoshita, Yuichi Yamada, Junki Maehara, Atsushi Kimura, Sadafumi Tamiya, Kenichi Taguchi, Tomoya Matsunobu, Yoshihiro Matsumoto, Yasuharu Nakashima, Masaaki Mawatari, Yoshinao Oda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Giant cell tumor of bone (GCTB) is an intermediate malignant bone tumor that is locally aggressive and rarely metastasizes. Denosumab, which is a receptor activator of nuclear factor kappa B ligand (RANKL) inhibitor, can be used to treat GCT
Externí odkaz:
https://doaj.org/article/15e54e693f844c898b660c77acb51cda
Autor:
Daisuke Kiyozawa, Kenichi Kohashi, Dai Takamatsu, Shinya Umekita, Masatoshi Eto, Mitsuru Kinjo, Kenichi Nishiyama, Kenichi Taguchi, Yumi Oshiro, Yusuke Kuboyama, Yoshinao Oda
Publikováno v:
Journal of Clinical Pathology; Feb2024, Vol. 77 Issue 2, p105-110, 6p
Autor:
Masashi Kaitsumaru, Masaki Shiota, Dai Takamatsu, Leandro Blas, Takashi Matsumoto, Junichi Inokuchi, Yoshinao Oda, Masatoshi Eto
Publikováno v:
International Cancer Conference Journal. 12:131-136
Autor:
Leandro Blas, Masaki Shiota, Dai Takamatsu, Fumio Kinoshita, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Publikováno v:
World Journal of Urology. 41:43-50
Conditional survival represents the probability of subsequent survival given that patients have already survived a certain length of time. Several models predict biochemical recurrence (BCR) after radical prostatectomy. However, none of them include
Autor:
Masaki, Shiota, Dai, Takamatsu, Takahiro, Kimura, Kojiro, Tashiro, Yoshiyuki, Matsui, Ryotaro, Tomida, Ryoichi, Saito, Masakazu, Tsutsumi, Akira, Yokomizo, Yoshiyuki, Yamamoto, Kohei, Edamura, Makito, Miyake, Shuichi, Morizane, Takayuki, Yoshino, Akihiro, Matsukawa, Shintaro, Narita, Ryuji, Matsumoto, Takashi, Kasahara, Kohei, Hashimoto, Hiroaki, Matsumoto, Masashi, Kato, Shusuke, Akamatsu, Akira, Joraku, Manabu, Kato, Takahiro, Yamaguchi, Toshihiro, Saito, Tomoyuki, Kaneko, Atsushi, Takahashi, Takuma, Kato, Shinichi, Sakamoto, Hideki, Enokida, Hidenori, Kanno, Naoki, Terada, Shigetaka, Suekane, Naotaka, Nishiyama, Masatoshi, Eto, Hiroshi, Kitamura
Publikováno v:
Cancer Science. 113:2386-2396
The treatment for lymph node involvement (LNI) after radical prostatectomy (RP) has not been established. This study aimed to reveal the outcomes of various management strategies among patients with LNI after RP. Retrospectively, 561 patients with LN
Autor:
Hiroki Komori, Leandro Blas, Masaki Shiota, Dai Takamatsu, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Publikováno v:
International Journal of Urology. 29:824-829
Nerve sparing may increase positive surgical margin rate during radical prostatectomy. Our objective was to analyze the positive surgical margin rate and location as well as its impact on biochemical recurrence according to nerve sparing procedure in
Autor:
Kosuke Ieiri, Nobuyuki Kakiuchi, Tomonori Hirano, Tomomi Nishimura, Koichi Watanabe, Hiroko Tanaka, Satoru Miyano, Dai Takamatsu, Keisuke Monji, Eiji Kashiwagi, Masaki Shiota, Junichi Inokuchi, Masatoshi Eto, Seishi Ogawa
Publikováno v:
Cancer Research. 83:6066-6066
Background: Chronic kidney disease is frequently associated with persistent inflammation, which results in fibrosis in the stroma, a reduced number of renal tubules, the formation of multiple cystic lesions, ultimately terminating in renal failure an
Autor:
Daisuke Kiyozawa, Kenichi Kohashi, Dai Takamatsu, Shinya Umekita, Masatoshi Eto, Mitsuru Kinjo, Kenichi Nishiyama, Kenichi Taguchi, Yumi Oshiro, Yusuke Kuboyama, Yoshinao Oda
Publikováno v:
Journal of clinical pathology.
AimsCollecting duct carcinoma (CDC) and fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) have similar histological morphologies and both show a poor prognosis. Programmed death ligand 1 (PD-L1) inhibitor has been approved for the
Autor:
Dai Takamatsu, Daisuke Kiyozawa, Kenichi Kohashi, Fumio Kinoshita, Yu Toda, Shin Ishihara, Masatoshi Eto, Yoshinao Oda
Publikováno v:
Pathology - Research and Practice. 244:154423